Microglia induce CD4 T lymphocyte final effector function and death

被引:218
作者
Ford, AL [1 ]
Foulcher, E [1 ]
Lemckert, FA [1 ]
Sedgwick, JD [1 ]
机构
[1] ROYAL PRINCE ALFRED HOSP,CENTENARY INST CANC MED & CELL BIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
关键词
D O I
10.1084/jem.184.5.1737
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Microglia, a type of tissue macrophage, are the only cells in the central nervous system (CNS) parenchyma to express some major histocompatibility complex (MHC) class II constitutively or to upregulate expression readily. They are thought to play a role in CD4 T cell activation in autoimmune diseases such as multiple sclerosis, as well as in neurodegenerative conditions, Alzheimer's disease in particular. We show here that highly purified MHC class II+ microglia when tested directly ex vivo do indeed support an effector response by an encephalitogenic myelin basic protein-reactive CD4 T cell line from which production of the proinflammatory cytokines, interferon gamma and tumor necrosis factor, is elicited, but not interleukin (IL)-2 secretion or proliferation. After this interaction, the T cells die by apoptosis. Other nonmicroglial but CNS-associated macrophages isolated in parallel stimulate full T cell activation, including IL-2 production, proliferation, and support T cell survival. Neither CNS-derived population expresses B7.1/B7.2. Resident macrophages that terminate effector T cells in tissues constitute a novel and broadly applicable regulatory measure of particular relevance to processes of self-tolerance against sequestered antigens.
引用
收藏
页码:1737 / 1745
页数:9
相关论文
共 46 条
[1]   Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-x(L)) but not pro-apoptotic (bax, bcl-x(S)) gene expression [J].
Akbar, AN ;
Borthwick, NJ ;
Wickremasinghe, RG ;
Panayiotidis, P ;
Pilling, D ;
Bofill, M ;
Krajewski, S ;
Reed, JC ;
Salmon, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) :294-299
[2]   Apoptosis in brain-specific autoimmune disease [J].
Bauer, J ;
Wekerle, H ;
Lassmann, H .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (06) :839-843
[3]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[4]   GROWTH-FACTORS CAN ENHANCE LYMPHOCYTE SURVIVAL WITHOUT COMMITTING THE CELL TO UNDERGO CELL-DIVISION [J].
BOISE, LH ;
MINN, AJ ;
JUNE, CH ;
LINDSTEN, T ;
THOMPSON, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5491-5495
[5]   THE SURFACE EXPRESSION OF A TUMOR-ASSOCIATED ANTIGEN ON HUMAN KAPPA-MYELOMA CELLS [J].
BOUX, HA ;
RAISON, RL ;
WALKER, KZ ;
MUSGROVE, E ;
BASTEN, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (03) :216-222
[6]  
CRISPE IN, 1994, IMMUNITY, V1, P347
[7]  
DESIMONE R, 1995, J NEUROPATH EXP NEUR, V54, P175
[8]   A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].
ESPEVIK, T ;
NISSENMEYER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105
[9]  
FORD AL, 1995, J IMMUNOL, V154, P4309
[10]   Balancing immunity and tolerance: Deleting and tuning lymphocyte repertoires [J].
Goodnow, CC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2264-2271